多分子形揭示了皮肤T细胞淋巴瘤中对免疫疗法的内源性和瘤反应

David R Glass1, Koshlan Mayer-Blackwell1, Nirasha Ramchurren2

  • 1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.

Cell reports. Medicine
|April 26, 2024
PubMed
概括

皮肤T细胞淋巴瘤 (CTCL) 的免疫疗法显示T细胞激活有限. 抗PD-1疗法增加了特定的T细胞类型,为这些皮肤癌的治疗反应提供了见解.